- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
You are here
Transdermal Delivery System for Tenofovir Alafenamide
Status
Stopped Early
Phase
Pre-clinical
Objective
The aim of this study was to develop a transdermal patch containing TAF and investigate its performance in vitro through human epidermis.
Prevention Option(s)
PrEP
Arms and Assigned Interventions
Description
Microarray transdermal patch
Products
F/TAF
Related Publications
Trial Sponsors
Eastern Virginia Medical School, CONRAD, Corporation of Mercer University, USAID/PEPFAR
Product Developers
CONRAD